Analysis: April Mcclain Delaney's buy of CHRW (C. H. ROBINSON WORLDWIDE, INC.)

Assessment: Low signal

Routine, programmatic addition to a core holdings list by a member with zero jurisdictional oversight or timeline-corroborated edge.

Executive summary

April Mcclain Delaney (House; member of the Agriculture Committee and the Science, Space, and Technology Committee) purchased CHRW on 2026-07-20 in the $1,001–$15,000 range (self), disclosed 2026-08-03 (14-day lag). SEC filings in the surrounding period include a 2026-07-24 8-K describing a $604 million advisory verdict in a Texas lawsuit (report date 2026-07-23) and a 2026-07-29 8-K furnishing Q2 2026 results. Within the user-provided trading history, CHRW shows repeated purchases in July 2026 following earlier CHRW sales in April/May 2026.

Based on the user-provided trading history, the 2026-07-20 CHRW purchase occurred alongside multiple same-day/next-day trades (buys: LTH, MLM; sells: SCI, LYV), all in relatively small disclosed ranges, consistent with batch-style portfolio activity rather than a single isolated CHRW action. The member’s CHRW activity shows 14 total trades from 2026-02-05 through 2026-07-31 (11 buys, 3 sells), with three CHRW sales in April/May 2026 that were matched to earlier buys and reported negative realized returns in the dataset; subsequently, the member made multiple CHRW purchases (including 2026-07-20, 2026-07-24, 2026-07-27, 2026-07-28, and 2026-07-31). From SEC EDGAR (user-provided enrichment), a CHRW 8-K dated July 23, 2026 (filed July 24, 2026) disclosed an advisory jury verdict in Dallas County, Texas, awarding $604 million in compensatory damages that could be assessed against the company (subject to post-trial proceedings). A separate 8-K filed July 29, 2026 furnished the company’s second-quarter 2026 results (Exhibit 99.1). Due to web access limitations in this environment, related congressional and regulatory catalysts (Congress.gov, Federal Register, Regulations.gov), USAspending award data, and the company’s most recent 10-K risk-factor/regulatory discussion could not be retrieved for corroboration or additional context.

Timeline

Independent analysis of public financial disclosures. Not financial or investment advice.

Sources

  1. sec.gov
  2. sec.gov
  3. sec.gov
  4. sec.gov
  5. sec.gov
  6. sec.gov

April Mcclain Delaney · CHRW · Trading news